Risk of HIV viral rebound in HIV infected patients on direct acting antivirals (DAAs) treatment for HCV

BACKGROUND: The dynamic of HIV-viral load (VL) remains poorly investigated in HIV/HCV patients under direct acting antivirals (DAAs). METHODS: We retrospectively evaluated HIV-VL at baseline (BL) during and up to 24 weeks post-DAAs in a cohort of 305 HIV-1/HCV patients, on ART and with no HIV virolo...

Descripción completa

Detalles Bibliográficos
Autores principales: Morsica, Giulia, Galli, Laura, Messina, Emanuela, Castagna, Antonella, Bagaglio, Sabrina, Salpietro, Stefania, Liviana, Della Torre, Uberti-Foppa, Caterina, Hasson, Hamid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812874/
https://www.ncbi.nlm.nih.gov/pubmed/35113890
http://dx.doi.org/10.1371/journal.pone.0262917

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812874/
https://www.ncbi.nlm.nih.gov/pubmed/35113890
http://dx.doi.org/10.1371/journal.pone.0262917

Ejemplares similares